Correction: OR7A10 GPCR engineering boosts CAR-NK therapy against solid tumors

Nature published an author correction for a study on OR7A10 GPCR engineering, which previously reported improvements in CAR-NK cell therapy for solid tumors. The correction addresses errors in the original paper, ensuring the findings are accurately represented. This matters as CAR-NK therapy is a promising cancer treatment, and accurate scientific reporting is crucial for its development.

Sources (1)